Clinical Trials Logo

Arthritis clinical trials

View clinical trials related to Arthritis.

Filter by:

NCT ID: NCT04884880 Not yet recruiting - Clinical trials for Arthritis, Rheumatoid

Efficacy and Safety of Luo-Fu-Shan Plaster in Patients With Rheumatoid Arthritis

Start date: May 14, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to assess the efficacy and safety of Luo-Fu-Shan Plaster in patients with Rheumatoid Arthritis.

NCT ID: NCT04825730 Not yet recruiting - Knee Arthritis Clinical Trials

Follow-up Study for Participants of Jointstem Investigator Initiated Trial by Arthroscopy

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

This clinical trial is conducted to assess the long-term safety of "jointstem" in patients with degenerative knee arthritis who participated in the previous BS-JS-IIT1 investigator initiated trial.

NCT ID: NCT04821102 Not yet recruiting - Knee Arthritis Clinical Trials

Investigator Initiated Trial to Evaluate Cartilage Regeneration by Arthroscopy After JOINTSTEM Administration

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to confirm cartilage regeneration through arthroscopy after a single administration of autologous Adipose Tissue derived Mesenchymal stem cells(JOINTSTEM) in patients with degenerative arthritis of K-L grade 3

NCT ID: NCT04815148 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid Arthritis

Start date: April 1, 2021
Phase: Phase 1
Study type: Interventional

This is a Phase Ia/Ib Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis and participants with Mild to Moderate Rheumatoid Arthritis.

NCT ID: NCT04791202 Not yet recruiting - Pain Clinical Trials

Hypertonic Dextrose Versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis

Start date: April 1, 2021
Phase: Phase 3
Study type: Interventional

The evolving reports form recent studies are creating a promise on the potential use of dextrose injections for treating arthritis and replacing current method of treating early osteoarthritis by corticosteroids by giving long standing effect and improving patients' symptoms and function. Over the past 5 years, an increasing number of level I and level II studies have emerged, examining the effect of intra-articular prolotherapy for the treatment of both hip and knee osteoarthritis. On the contrary, there is limited data in small joints, such as the temporomandibular joint.

NCT ID: NCT04791189 Not yet recruiting - Clinical trials for Juvenile Idiopathic Arthritis

Survey on the Expectations of Adolescents With Juvenile Idiopathic Arthritis (JIA) Regarding Knowledge and Communication With Health Care Professionals in the Field of Sexual Health, and Their Parents' Views on the Subject. (SNAPS-JIA)

SNAPS-JIA
Start date: May 2021
Phase:
Study type: Observational

Sexual health is a legitimate area to explore in the care of these patients, as it has such an impact on quality of life. However, addressing sexual health in a situation of chronic disease confronts the double societal taboo of disease and sexuality. Health professionals are uncomfortable because they are not trained to talk about the subject, especially in the presence of parents and with a teenager they have watched grow up. In this context, a needs survey among juvenile idiopathic arthritis (JIA) patients and the point of view of their parents in the field of sexual health seems necessary. Main objective: To determine the expectations of adolescents (aged 10-19 years) with juvenile idiopathic arthritis regarding knowledge and communication with health care professionals in the field of sexual health.

NCT ID: NCT04784156 Not yet recruiting - Foot Arthritis Clinical Trials

Use of a Sustained Dynamic Compression Intramedullary Nail for Subtalar Arthrodesis

Start date: June 2021
Phase:
Study type: Observational

The purpose of this study is to determine the clinical efficacy of a novel dynamic sustained compression intramedullary nail for subtalar (talocalcaneal) arthrodesis.

NCT ID: NCT04652791 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

A Study to Assess Efficacy and Safety of Wangbi Capsule in Patients With Rheumatoid Arthritis

Start date: December 2020
Phase:
Study type: Observational [Patient Registry]

The aim of this multi-center, prospective, non-interventional cohort study is to evaluate the efficacy and safety of Wangbi capsule for rheumatoid arthritis patients in the real-world setting.

NCT ID: NCT04585711 Not yet recruiting - Obesity Clinical Trials

Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis

PRECISE
Start date: July 1, 2024
Phase: Phase 1
Study type: Interventional

The purpose of this study is to learn more about how adult and children's bodies use etanercept and how bodyweight influences how well etanercept works. This study will help us understand the proper dose of etanercept in obese children and adults.

NCT ID: NCT04569890 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Treatment of Pregnancy RA

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

It is important to control the disease of pregnant women with rheumatoid arthritis to ensure the fetal and maternal health. Frequent disease flare can increase the risk of adverse pregnancy outcomes, including abortion, premature delivery and low birth weight. However, there is no scientific and standardized treatment strategy for RA during pregnancy. About 50% of RA patients need treatment during pregnancy. Tumor necrosis inhibitor (TNFi) is an effective treatment, which can significantly improve the symptoms of RA during pregnancy. However, in order to avoid placental metastasis, TNFi is usually stopped in early pregnancy. Certolizumab pegol (CZP) is a PEGylated, Fc-free TNFi, which does not bind FcRn and is consequently not expected to undergo FcRn-mediated transfer across the placenta. Therefore, it can not transfer through placenta into FcRn and is approved to treat RA during pregnancy. This study focuses on patients with RA who consider pregnancy. We compared the efficacy, safety and economy of CZP and glucocorticoids combined with hydroxychloroquine by a randomized controlled trial.